相似文献
1
Rare Breast Cancer Subtypes.
Curr Oncol Rep. 2021 Mar 23;23(5):54. doi: 10.1007/s11912-021-01048-4.
2
Rare breast cancer subtypes: histological, molecular, and clinical peculiarities.
Oncologist. 2014 Aug;19(8):805-13. doi: 10.1634/theoncologist.2014-0108. Epub 2014 Jun 26.
3
Influence of breast cancer histology on the relationship between ultrasound and pathology tumor size measurements.
Mod Pathol. 2004 Aug;17(8):905-10. doi: 10.1038/modpathol.3800138.
4
The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Breast Cancer. 2021 Jan;28(1):187-195. doi: 10.1007/s12282-020-01146-4. Epub 2020 Aug 18.
5
Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.
Breast Dis. 2008;30:15-9. doi: 10.3233/BD-2009-0278.
6
Neuroendocrine breast carcinoma: a rare but challenging entity.
Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4.
7
[Histopathologic grading of breast cancer; large variation with major consequences?].
Ned Tijdschr Geneeskd. 2021 Jan 14;164:D5441.
8
A foundation model for clinical-grade computational pathology and rare cancers detection.
Nat Med. 2024 Oct;30(10):2924-2935. doi: 10.1038/s41591-024-03141-0. Epub 2024 Jul 22.
9
Unusual breast cancers: useful clues to expanding the differential diagnosis.
Radiology. 2007 Mar;242(3):683-94. doi: 10.1148/radiol.2423051631.
10
Challenges and potential pitfalls in magnetic resonance imaging of more elusive breast carcinomas.
Semin Ultrasound CT MR. 2011 Aug;32(4):342-50. doi: 10.1053/j.sult.2011.03.004.
引用本文的文献
1
Mucinous carcinoma of the breast: epidemiological, clinical, and prognostic characteristics; a single-center experience.
Discov Oncol. 2025 Jul 23;16(1):1396. doi: 10.1007/s12672-025-03146-2.
2
associated ceRNA-HOTAIR pathway in breast cancer patients from clinicopathological perspective.
Turk J Med Sci. 2025 May 30;55(3):782-791. doi: 10.55730/1300-0144.6027. eCollection 2025.
3
Rare presentation of multicentric sebaceous carcinoma of the breast in a 33-year-old woman: diagnostic challenges and treatment approach.
Ecancermedicalscience. 2025 May 15;19:1908. doi: 10.3332/ecancer.2025.1908. eCollection 2025.
4
Characterization of intrinsic subtypes of breast cancer and their relationship with staging: an observational study.
Front Med (Lausanne). 2025 May 9;12:1553910. doi: 10.3389/fmed.2025.1553910. eCollection 2025.
5
Rare Histological Types of Breast Cancer: A Single-Center Experience.
Breast J. 2025 Mar 9;2025:1179914. doi: 10.1155/tbj/1179914. eCollection 2025.
6
Complex Role of Circulating Triglycerides in Breast Cancer Onset and Survival: Insights From Two-Sample Mendelian Randomization Study.
Cancer Med. 2025 Feb;14(4):e70698. doi: 10.1002/cam4.70698.
7
Low-Grade Adenosquamous Carcinoma of the Breast: A Single-Center Retrospective Study and a Systematic Literature Review.
Cancers (Basel). 2024 Dec 20;16(24):4246. doi: 10.3390/cancers16244246.
8
Metaplastic carcinoma of the breast containing three histological components: a case report.
Front Oncol. 2024 Dec 19;14:1470986. doi: 10.3389/fonc.2024.1470986. eCollection 2024.
9
Automated Identification of Breast Cancer Relapse in Computed Tomography Reports Using Natural Language Processing.
JCO Clin Cancer Inform. 2024 Dec;8:e2400107. doi: 10.1200/CCI.24.00107. Epub 2024 Dec 20.
10
The Genomic and Biologic Landscapes of Breast Cancer and Racial Differences.
Int J Mol Sci. 2024 Dec 7;25(23):13165. doi: 10.3390/ijms252313165.
本文引用的文献
1
Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers.
J Surg Oncol. 2020 Nov;122(6):1232-1239. doi: 10.1002/jso.26129. Epub 2020 Jul 15.
2
Special type breast carcinoma: Sebaceous carcinoma of the breast; A case report and review of literature.
Breast J. 2020 Oct;26(10):2034-2037. doi: 10.1111/tbj.13963. Epub 2020 Jul 4.
3
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions.
Crit Rev Oncol Hematol. 2020 Aug;152:103011. doi: 10.1016/j.critrevonc.2020.103011. Epub 2020 May 31.
4
Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas.
Mod Pathol. 2020 Dec;33(12):2473-2482. doi: 10.1038/s41379-020-0589-x. Epub 2020 Jun 5.
5
Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies.
Breast. 2020 Jun;51:11-20. doi: 10.1016/j.breast.2020.01.041. Epub 2020 Jan 29.
6
Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society.
J Breast Cancer. 2019 Dec;22(4):599-612. doi: 10.4048/jbc.2019.22.e46.
7
Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis.
Breast. 2020 Feb;49:87-92. doi: 10.1016/j.breast.2019.11.002. Epub 2019 Nov 11.
8
Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
Cancer Med. 2019 Dec;8(18):7523-7531. doi: 10.1002/cam4.2634. Epub 2019 Oct 23.
9
Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
Breast Cancer Res. 2019 Oct 17;21(1):113. doi: 10.1186/s13058-019-1201-5.
10
Clear cell carcinoma of breast lipid-rich variant.
J Cancer Res Ther. 2019 Jul-Sep;15(5):1167-1169. doi: 10.4103/jcrt.JCRT_870_17.
Zotero 插件